The trio of executives walking KaloBios Pharmaceuticals Inc. through bankruptcy protection could get $700,000 in equity awards from the company, according to a regulatory filing by the company once led by widely reviled investor and pharmaceutical executive Martin Shkreli.The Brisbane company would make one-time equity awards of at least $300,000 each to directors Ronald Barliant and David Moradi and at least $100,000 to Chairman and CEO Dr. Cameron Durrant.
Join the conversation: Follow @SFBusinessTimes…
Walang komento:
Mag-post ng isang Komento